TY - JOUR T1 - New insights into nCOVID-19 binding domain and its cellular receptors JF - bioRxiv DO - 10.1101/2020.09.06.285023 SP - 2020.09.06.285023 AU - Ankush Garg AU - Gaurav Kumar AU - Sharmistha Sinha Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/09/06/2020.09.06.285023.abstract N2 - nCOVID-19 virus makes cellular entry using its spike protein protruding out on its surface. Angiotensin converting enzyme 2 receptor has been identified as a receptor that mediates the viral entry by binding with the receptor binding motif of spike protein. In the present study, we elucidate the significance of N-terminal domain of spike protein in spike-receptor interactions. Recent clinical reports indicate a link between nCOVID-19 infections with patient comorbidities. The underlying reason behind this relationship is not clear. Using molecular docking, we study the affinity of the nCOVID-19 spike protein with cell receptors overexpressed under disease conditions. Our results suggest that certain cell receptors such as DC/L-SIGN, DPP4, IL22R and ephrin receptors could act as potential receptors for the spike protein. The receptor binding domain of nCOVID-19 is more flexible than that of SARS-COV and has a high propensity to undergo phase separation. Higher flexibility of nCOVID-19 receptor binding domain might enable it to bind multiple receptor partners. Further experimental work on the association of these receptors with spike protein may help us to explain the severity of nCOVID-19 infection in patients with comorbidities.Competing Interest StatementThe authors have declared no competing interest. ER -